Trials / Completed
CompletedNCT01625871
Artemether/Lumefantrine and Vivax Malaria
Artemether/Lumefantrine in the Treatment of Plasmodium Vivax Malaria in Eastern Sudan
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- University of Khartoum · Academic / Other
- Sex
- All
- Age
- 5 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The cure rate of artemether/lumefantrine in the treatment of vivax malaria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tablets artemether/lumefantrine | six doses of oral tablets of artemether/lumefantrine |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2012-06-22
- Last updated
- 2013-01-17
Locations
1 site across 1 country: Sudan
Source: ClinicalTrials.gov record NCT01625871. Inclusion in this directory is not an endorsement.